What Makes 2010 Different?

What Makes 2010 Different From The Past?

 

  • Bring home new insights from 8 all new case studies from GlaxoSmithKline, Pfizer, Takeda, Dow Agrosciences, and more

  • Hear new white paper updates from the IPWG (Industry Pharmacogenomics Working Group) on standards and best practices across the biopharma industry

  • Direct your focus towards the future of biospecimen biobanking with 3 case studies from both pharma and academia on utilizing biobanking best practices to drive forward biospecimen science, biomarker discovery, and drug development

  • Overcome data privacy and ethical concerns with a panel discussion representing a broad range of industry perspectives including pharma, academia, legal, NCI, ethical committees, and the VA biorepository

  • Answer your biggest questions as interactive round table discussions delve into a wide range of critical industry challenges offering additional networking opportunities and focused instructional time to gain solutions to your top concerns

  • Engage in the 3rd gathering of the Industry Standards Working Group in the half-day workshop to streamline guidelines and create consistency across the industry

  • Learn the nuts and bolts of establishing and growing a biorepository to fit your needs in the full day symposium from industry leaders including Millennium and Gilead Sciences

  • Discover the industry’s latest technologies, products, and services in our Quick Fire Technology Spotlights. These 15 minute technology showcases offer you exposure to the future of biospecimen management with innovative technology such inventory management systems, automation technology, and more